Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial.
Liu Y, Luo X, Liu J, Ma Y, Tan J, Wang W, Hu J, Fu X, Xu L, Yu F, Xu S, Ma H, Yu X, You Q, Wang Z, Li L, Zhang X, Sun X.
Phytomedicine. 2023 May;113:154723. doi: 10.1016/j.phymed.2023.154723. Epub 2023 Feb 21.
PMID:36871476
Induction chemotherapy followed by radical chemoradiotherapy for patients with stage IV non-metastatic nasopharyngeal carcinoma: 11-Year Experience in a tertiary centre.
Choi WYL, Lai JWY, Yu ELM, Choy YH, Lam YN, Wong RKY, Cheng ACK.
J Med Imaging Radiat Oncol. 2022 Sep;66(6):853-865. doi: 10.1111/1754-9485.13400. Epub 2022 Mar 18.
PMID:35302281
Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
Editorial Comment on "Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer".
Cabral JD, Modi PK.
Urology. 2024 Sep;191:85. doi: 10.1016/j.urology.2024.06.024. Epub 2024 Jun 20.
PMID:38908567
Radical D2 gastrectomy with adjuvant chemotherapy for stage IB/II/III distal gastric cancers in the era of perioperative chemotherapy: A propensity matched comparison.
Am J Surg. 2022 Jun;223(6):1055-1062. doi: 10.1016/j.amjsurg.2021.10.036. Epub 2021 Oct 27.
PMID:34756584
Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysis.
Nagaoka S, Yamashita H, Seto Y, Fujisaki M, Mitsumori N, Oshima Y, Yajima S, Kikuchi Y, Otsuka K, Murakami M, Fujita S, Futawatari N, Shimada H.